
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.9B | -- | -- | -- | -- |
07/23/2025 | Q2 | $2B | -- | -- | -- | -- |
04/25/2025 | Q1 | $1.8B | $1.8B | -$0.06 | -- | -- |
02/20/2025 | Q4 | $1.9B | $1.8B | -$0.06 | -- | -- |
10/23/2024 | Q3 | $2B | $1.9B | $0.10 | -- | -- |
07/24/2024 | Q2 | $2.1B | $2B | $0.20 | -- | -- |
04/25/2024 | Q1 | $2B | $1.9B | -$0.08 | -- | -- |
12/31/2023 | Q4 | $1.8B | $1.8B | -$0.08 | -- | -- |
09/30/2023 | Q3 | -- | -- | $0.08 | -- | -- |
06/30/2023 | Q2 | -- | -- | $0.01 | -- | -- |
03/31/2023 | Q1 | -- | -- | $0.06 | -- | -- |
12/31/2022 | Q4 | -- | -- | -$0.04 | -- | -- |
09/30/2022 | Q3 | -- | -- | $0.08 | -- | -- |
06/30/2022 | Q2 | -- | -- | $0.28 | -- | -- |
03/31/2022 | Q1 | -- | -- | $0.26 | -- | -- |
12/31/2021 | Q4 | -- | -- | $0.12 | -- | -- |
09/30/2021 | Q3 | -- | -- | $0.22 | -- | -- |
06/30/2021 | Q2 | -- | -- | $0.22 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.16 | -- | -- |
12/31/2020 | Q4 | -- | -- | $0.07 | -- | -- |
09/30/2020 | Q3 | -- | -- | $0.07 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.01 | -- | -- |
03/31/2020 | Q1 | -- | -- | $0.04 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$0.00 | -- | -- |
09/30/2019 | Q3 | -- | -- | $0.07 | -- | -- |
06/30/2019 | Q2 | -- | -- | $0.08 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.05 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.03 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.12 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.20 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.08 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.01 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.10 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.08 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.04 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.10 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.22 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.12 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.06 | -- | -- |
12/31/2015 | Q4 | -- | -- | $0.00 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.06 | -- | -- |
Orbia Advance Corp SAB de CV reported $1.8B worth of top line sales in its most recent quarter.
Orbia Advance Corp SAB de CV announced earnings per share of -$0.06 which represents a miss of analyst forecast a -- per share.
Orbia Advance Corp SAB de CV reported $394M that represents $0.44 per share over the last quarter.
Orbia Advance Corp SAB de CV's earnings are forecast to grow from $0.16 per share to -- per share next year representing an increase of --.
Orbia Advance Corp SAB de CV's next earnings date is July 23, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.